3 reasons digital-healthcare pioneer Hims is staying out of the latest weight-loss craze for now
two obesity-medicine specialists to its medical-advisory board to help evaluate the market. But Dudum said he thinks it's too early to jump into the ring.
"I don't believe it's in our company's interest to ever be the first mover when it comes to expanding into new categories," Dudum said. Dudum named three major factors about the current state of GLP-1 prescriptions that have given him pause about rolling out a weight-management program at Hims right now — from a lack of evidence of how GLP-1s can affect patients long term, to disruptions in access to the drugs with drug shortages, and unreliable insurance coverage.Dudum expressed concerns about the lack of data on long-term GLP-1 usage for weight loss.
"We're still in the very early innings with regard to what it means long-term, frankly because there have been no patients that have taken this drug long term for obesity," he said.
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Why Stephen King Doesn't Write Sequels (& Why He Still Has)Stephen King has avoided writing sequels to most of his works, and he has a good reason for that, though he has still written a couple of follow-ups.
Leer más »
Stock trader who returned 2,700% shares top 3 indicators he usesA stock trader who's returned 2,700% in the last 3 years shares the 3 indicators he uses as his guides to buy and sell
Leer más »
Stock Market Crash: 45% Downside Ahead For S&P 500, Expert WarnsA 31-year market vet who called the current bear market says the S&P 500 has another 45% downside as investors remain blind to signs that a recession is hurtling toward the US economy
Leer más »
Tesla's cut prices in the US yet again, this time by as much as $5,000Insider tells the global tech, finance, markets, media, healthcare, and strategy stories you want to know.
Leer más »
29 stocks to buy with underrated earnings: Goldman SachsInsider tells the global tech, finance, markets, media, healthcare, and strategy stories you want to know.
Leer más »
Coolest cars at the 2023 New York auto show: Lamborghini, Hyundai, ToyotaThe coolest cars we saw at the New York auto show, from a sleek electric Hyundai to an all-terrain Lamborghini
Leer más »